We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$9.8B
AUM Growth
-$1.96B
(-17%)
Cap. Flow
-$53.6M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
15.05%
Holding
1,967
New
854
Increased
344
Reduced
350
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$97.9M |
| 2 |
SHPG
Shire pic
SHPG
|
+$80.3M |
| 3 |
Teleflex
TFX
|
+$76.7M |
| 4 |
Accenture
ACN
|
+$74.6M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$74.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$140M |
| 2 |
Quest Diagnostics
DGX
|
+$97.7M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$94.3M |
| 4 |
Tractor Supply
TSCO
|
+$78.2M |
| 5 |
AET
Aetna Inc
AET
|
+$77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.48% |
| 2 | Consumer Discretionary | 18.77% |
| 3 | Technology | 12.96% |
| 4 | Financials | 11.62% |
| 5 | Industrials | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Antero Midstream
AM
$10.8B
| $8.28M | 0.08% |
741,000
+729,265
| +6,214% | +$11.1M |
|
|
SGMO
302
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $8.18M | 0.08% |
712,657
+699,089
| +5,152% | +$8.68M |
|
|
TFCF
303
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $8.17M | 0.08% |
170,921
+55,841
| +49% | +$2.63M |
|
304
HUB Group
HUBG
$3.01B
| $8.16M | 0.08% |
+440,192
| New | +$9.44M |
|
|
PENG
305
Penguin Solutions Inc
PENG
$2.76B
| $8.13M | 0.08% |
547,582
+379,426
| +226% | +$5.74M |
|
306
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $8.08M | 0.08% |
+257,796
| New | +$10.6M |
|
307
Mueller Water Products
MWA
$3.92B
| $8.07M | 0.08% |
+887,009
| New | +$9.3M |
|
|
AAWW
308
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $7.99M | 0.08% |
189,381
+184,604
| +3,864% | +$9.45M |
|
309
Red Rock Resorts
RRR
$3.74B
| $7.93M | 0.08% |
390,671
-741,205
| -65% | -$17.4M |
|
310
General Mills
GIS
$19.2B
| $7.88M | 0.08% |
+202,314
| New | +$8.55M |
|
311
Assembly Biosciences
ASMB
$506M
| $7.73M | 0.08% |
28,481
+3,297
| +13% | +$954K |
|
312
Exponent
EXPO
$2.98B
| $7.73M | 0.08% |
152,390
+108,966
| +251% | +$5.47M |
|
313
Texas Roadhouse
TXRH
$12.7B
| $7.72M | 0.08% |
129,397
-45,550
| -26% | -$2.92M |
|
|
CBLK
314
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $7.72M | 0.08% |
+575,571
| New | +$9.46M |
|
315
Sumitomo Mitsui Financial
SMFG
$166B
| $7.71M | 0.08% |
+1,183,726
| New | +$8.84M |
|
316
Gilead Sciences
GILD
$161B
| $7.7M | 0.08% |
123,013
-134,351
| -52% | -$9.39M |
|
|
CMD
317
DELISTED
Cantel Medical Corporation
CMD
| $7.69M | 0.08% |
103,265
-22,402
| -18% | -$1.85M |
|
318
Corcept Therapeutics
CORT
$10.2B
| $7.67M | 0.08% |
573,836
+456,584
| +389% | +$6.03M |
|
319
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $7.66M | 0.08% |
+166,196
| New | +$8.82M |
|
320
Robert Half
RHI
$3.61B
| $7.6M | 0.08% |
+132,871
| New | +$8.15M |
|
321
Hanover Insurance
THG
$7.63B
| $7.58M | 0.08% |
64,944
-176,260
| -73% | -$19.8M |
|
322
Vulcan Materials
VMC
$36.3B
| $7.58M | 0.08% |
76,722
+70,882
| +1,214% | +$7.19M |
|
323
Paylocity
PCTY
$6.71B
| $7.53M | 0.08% |
125,022
-464,774
| -79% | -$29.8M |
|
324
Sunstone Hotel Investors
SHO
$2.19B
| $7.51M | 0.08% |
576,964
+555,098
| +2,539% | +$8.17M |
|
|
BFYT
325
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $7.49M | 0.08% |
280,288
-23,241
| -8% | -$932K |
|
Similar funds
Marshall Wace's Q4 2018 Portfolio in Review
As of Q4 2018, Marshall Wace held 1,967 positions worth $9.8B, down 17% from $11.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Marshall Wace's Q4 2018 filing shows 854 new, 344 increased, 350 reduced and 392 closed positions. Its largest new stake was Mastercard: 339,646 shares worth $64.1M. The largest sale was McDonald's, an estimated $140M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
- Marshall Wace's largest Q4 2018 buy was Mastercard: 339,646 shares worth $64.1M.
- Marshall Wace added most to Alphabet (Google) Class A in Q4 2018, an estimated $97.9M increase.
- Marshall Wace's biggest Q4 2018 reduction was McDonald's, cutting an estimated $140M.
- Marshall Wace fully exited Aetna Inc in Q4 2018, selling an estimated $77M.
- Marshall Wace's ten largest holdings make up 15% of its $9.8B portfolio in Q4 2018.
- Marshall Wace opened 854 new positions and closed 392 in Q4 2018.
- Marshall Wace's portfolio value fell 17% quarter-over-quarter to $9.8B.
Based on Marshall Wace's 13F filing for Q4 2018, filed 14 Feb 2019.